Vascular Biogenics Profile

2.22
USD 0.005  0.22%
3%
40%

Vascular Biogenics Summary

Vascular Biogenics Ltd (VBLT) is traded on NASDAQ General Markets in USA. It is located in ISRAEL and employs 37 people. Vascular Biogenics is listed under Pharmaceutical Products category by Fama And French industry classification.The company currently falls under 'Micro-Cap' category with current market capitalization of 66.52 M. Vascular Biogenics Ltd conducts business under Healthcare sector and is part of Pharmaceutical Products industry. This company has 29.9 M outstanding shares of which 799.77 K shares are at this time shorted by private and institutional investors with about 2.25 trading days to cover. Vascular Biogenic currently holds about 54.73 M in cash with (3.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.83.
Check Vascular Biogenics Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
about 22.52%30 days 2.22  about 77.44%
Based on normal probability distribution, the odds of Vascular Biogenics to move above current price in 30 days from now is about 77.44% (This Vascular Biogenics Ltd probability density function shows the probability of Vascular Biogenics Stock to fall within a particular range of prices over 30 days) .

Top Holders

Selected Vascular Biogenics Ltd Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Vascular Biogenics Against Markets

Risk Adjusted
Performance Score (0 to 100)
0 
Chance of
Financial Distress (0 to 100%)
< 78% 
Equity ratings for Vascular Biogenics Ltd are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Vascular Biogenics Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for cancer. Vascular Biogenics Ltd. was founded in 2000 and is headquartered in Modiin, Israel. Vascular Biogenics operates under Biotechnology classification in USA and traded on NASDAQ General Markets. It employs 37 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
NameVascular Biogenics Ltd
CEO, DirectorDror HaratsView All
Thematic Classification
Currently Active Investing Idea
  Pharmaceutical Products
View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
InstrumentUSA Stock View All
LocationISRAEL
Business Address8 HaSatat Street
ExchangeNASDAQ General Markets
CUSIPM96883109
SectorHealthcare
IndustryPharmaceutical Products
BenchmarkDOW
Websitewww.vblrx.com
Contact Number972 8 993 5000
CurrencyUSD - US Dollar

Recommendations

Vascular Biogenics Analyst Recommendations
Target PriceAdvice# of Analysts
14.0Strong Buy3Odds
Vascular Biogenics Ltd current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Vascular Biogenics Analyst Advice  

Earnings

Vascular Biogenics Earnings Estimates
EPSEstimate Date
Quarterly Estimate-0.14April 4, 2017
Vascular Biogenics Ltd normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Vascular Biogenics Corporate Directors
Philip Serlin Non-Executive Independent Director
Dan Gelvan Non-Executive Independent Director
Ron Cohen Non-Executive Independent Director, Ph.D
Also please take a look at World Market Map. Please also try ETF Directory module to find actively-traded exchange traded funds (etf) from around the world.